AIkido Pharma Inc. logo

AIkido Pharma (AIKI) stock

AIKI · AIkido Pharma Inc. · NASDAQ

Website

What is the latest news on AIKI stock?

13D/Gago
SEC Form SC 13D filed by AIkido Pharma Inc.

SC 13D - Dominari Holdings Inc. (0000012239) (Subject)

All AIKI news

Latest news

25 items

AIkido Pharma Inc. (AIKI) is a Specialty Chemicals company listed on NASDAQ. There were no new wire items for AIKI in the last 30 days. The most recent was published Dec 28, 2023.

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York.

AIKI FAQ

6 questions
  • What does AIkido Pharma Inc. do?
    AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement...
  • Where does AIKI stock trade?
    AIkido Pharma Inc. (AIKI) is listed on NASDAQ.
  • What sector and industry is AIKI in?
    AIkido Pharma Inc. operates in the Consumer Discretionary sector, Specialty Chemicals industry.
  • What are analysts saying about AIKI?
    AIkido Pharma Inc. has had 1 recent analyst action on file. The most recent action was from HC Wainwright & Co.: Buy with a $2.00 price target on 2021-10-11. Recent price targets cluster around $2.00.
  • What companies are similar to AIKI?
    Notable peers in the same industry include ASH (Ashland Inc.), CLX (Clorox Company), ZONE (Zone Frontier Inc.), CSL (Carlisle Companies Incorporated), NPT (Texxon Holding Limited). Compare AIKI side-by-side with any of them on Quantisnow.
  • How can I track AIKI on Quantisnow?
    Quantisnow aggregates AIkido Pharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AIKI to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change